- Public Comps
- Company K Partners
Company K Partners Valuation Multiples
Discover Company K Partners' revenue and EBITDA valuation multiples and investment history, alongside public comparables like LB Investment, Quest for Growth, Brookfield Glb Infr Secs, SV Investment and more.
Company K Partners Overview
About Company K Partners
Company K Partners Ltd is a South Korea based venture capital company involved in partnering with entrepreneurs to deliver market-transforming value in new industrial frontiers. The portfolio of investments of the company include Equity investment in the sectors of Internet, Mobile, Software, Healthcare and Project Investment.
Founded
2006
HQ

Employees
N/A
Website
Sectors
Financials (FY)
EV
$63M
Valuation Multiples
Start free trialCompany K Partners Financials
Company K Partners reported last fiscal year revenue of $15M and EBITDA of $7M.
In the same fiscal year, Company K Partners generated $13M in gross profit, $7M in EBITDA, and $5M in net income.
Company K Partners P&L
In the most recent fiscal year, Company K Partners reported revenue of $15M and EBITDA of $7M.
Company K Partners is profitable as of last fiscal year, with gross margin of 85%, EBITDA margin of 48%, and net margin of 34%.
Financial data powered by Morningstar, Inc.
Company K Partners Stock Performance
Company K Partners has current market cap of $69M, and enterprise value of $63M.
Market Cap Evolution
Company K Partners' stock price is $4.41.
Company K Partners share price increased by 9.0% in the last 30 days, and by 6.7% in the last year.
Company K Partners has an EPS (earnings per share) of $0.33.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $63M | $69M | 1.1% | 9.0% | -16.9% | 6.7% | $0.33 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialCompany K Partners Valuation Multiples
Company K Partners trades at 4.1x EV/Revenue multiple, and 8.6x EV/EBITDA.
Company K Partners Financial Valuation Multiples
As of August 9, 2026, Company K Partners has market cap of $69M and EV of $63M.
Company K Partners has a P/E ratio of 13.4x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Company K Partners Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Company K Partners Margins & Growth Rates
In the most recent fiscal year, Company K Partners reported gross margin of 85%, EBITDA margin of 48%, and net margin of 34%.
Company K Partners Margins
Company K Partners Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Company K Partners Operational KPIs
Data powered by FactSet, Inc. and Morningstar, Inc.
Company K Partners Competitors
Company K Partners competitors include LB Investment, Quest for Growth, Brookfield Glb Infr Secs, SV Investment, Atinum Investment, Alpha, Stonebridge Ventures, DY, Agronomics and SBI Investment KOREA.
Most Company K Partners public comparables operate across PE & VC.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 2.7x | - | 7.0x | - | |||
| (36.9x) | - | - | - | |||
| 8.5x | - | - | - | |||
| 5.2x | - | (61.9x) | - | |||
| 0.9x | - | 1.8x | - | |||
| 0.3x | 0.3x | 3.8x | - | |||
| 2.4x | - | 4.2x | - | |||
| 0.1x | - | 1.9x | - | |||
This data is available for Pro users. Sign up to see all Company K Partners competitors and their valuation data. Start Free Trial | ||||||
Investments by Company K Partners
Company K Partners has invested in 109 companies to date.
Latest investment by Company K Partners was on July 22nd 2026. Company K Partners invested in Prazer Therapeutics in their $32M Undisclosed stage round (EV/Revenue multiple available to Pro users).
Latest Investments by Company K Partners
| Description | Prazer Therapeutics is a biotechnology firm developing treatments for intractable diseases using rational molecular drug design and next-generation protein degradation technologies. Based in South Korea, the company focuses on targeted therapies for oncology and rare genetic disorders, leveraging proprietary platforms to engineer protein degraders that selectively eliminate disease-causing proteins. Prazer collaborates with academic institutions and advances candidates through preclinical stages toward clinical trials. | EtherNafusion is a South Korean technology startup that develops small-scale modular fusion reactors. | XCENA is a startup designing intelligent memory and memory-centric computing architectures utilizing CXL technology. The company targets high-performance data processing advancements for data centers and AI applications. | WIRobotics is a wearable robotics company in Cambridge, Massachusetts, developing exosuits to reduce physical strain. Its devices assist workers in manufacturing and logistics, cutting injury rates by 30 percent. WIRobotics pilots with Amazon warehouses. Founded in 2019, it raised $10 million for commercialization. | |
| HQ Country | |||||
| HQ City | Seoul | Seoul | Seongnam | Yongin | |
| Deal Date | 22 Jul 2026 | 5 Jul 2026 | 28 May 2026 | 14 May 2026 | |
| Round | Undisclosed stage | Seed | Series B | Series B | |
| Raised | $32M | $2M | $135M | $65M | |
| Investors | Woori Venture Partners; Smilegate Investment; Playground Global; Premier Partners; K2 Investment Partners; Company K Partners; Johnson & Johnson Innovation | Seoul Techno Holdings; Bluepoint; Company K Partners | KDB Capital; STIC Ventures; IMM Investment; Korea Development Bank; Kiwoom Investment; SV Investment; K2 Investment Partners; Kyobo Securities; Company K Partners; Partners Investment; Atinum Investment; SBI Investment KOREA | Hana Ventures; Smilegate Investment; SBVA; NH Investment & Securities; InterVest Co.; GU Equity Partners; Company K Partners; JB Investment; FuturePlay | |
| Valuation | undisclosed | undisclosed | $570M | undisclosed | |
| EV/Revenue | |||||
| EV/EBITDA | |||||
This data is available for Pro users. Sign up to see all Company K Partners investments and their VC round multiples. Start Free Trial | |||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Company K Partners
| When was Company K Partners founded? | Company K Partners was founded in 2006. |
| Where is Company K Partners headquartered? | Company K Partners is headquartered in South Korea. |
| Is Company K Partners publicly listed? | Yes, Company K Partners is a public company listed on Korea Exchange. |
| What is the stock symbol of Company K Partners? | Company K Partners trades under 307930 ticker. |
| When did Company K Partners go public? | Company K Partners went public in 2019. |
| Who are competitors of Company K Partners? | Company K Partners main competitors include LB Investment, Quest for Growth, Brookfield Glb Infr Secs, SV Investment, Atinum Investment, Alpha, Stonebridge Ventures, DY, Agronomics, SBI Investment KOREA. |
| What is the current market cap of Company K Partners? | Company K Partners' current market cap is $69M. |
| What is the current revenue of Company K Partners? | Company K Partners' last fiscal year revenue is $15M. |
| What is the current EV/Revenue multiple of Company K Partners? | Current revenue multiple of Company K Partners is 4.1x. |
| Is Company K Partners profitable? | No, Company K Partners is not profitable. |
| How many companies Company K Partners has acquired to date? | Company K Partners hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Company K Partners has invested to date? | As of August 2026, Company K Partners has invested in 109 companies. |
| What was the last Company K Partners investment? | On 22nd July 2026 Company K Partners invested in Prazer Therapeutics, participating in a $32M Undisclosed stage round, alongside Woori Venture Partners, Smilegate Investment, Playground Global, Premier Partners, K2 Investment Partners, and Johnson & Johnson Innovation. |
| In what companies Company K Partners invested in? | Company K Partners invested in XCENA, Upstage, WIRobotics, CHAI, Mobilint, HyperAccel, Banksalad, Rainist, Curocell, Prazer Therapeutics, Rapport Labs, OncXerna Therapeutics, RIDI, Kmong, Balaan, J2H Biotech, Jaranda, Catch Table, Mediquitous, KoBioLabs, and 89 other companies. |
See public comps similar to Company K Partners
Lists including Company K Partners
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.





